Term Sheets in the Biotechnology Industry

32 Contracts & Agreements

Browse by Company

Adamas Pharmaceuticals Inc (2 contracts)
Alkermes plc. (1)
Alliqua BioMedical, Inc. (1)
AzurRx BioPharma, Inc. (1)
Calyxt, Inc. (1)
Clovis Oncology, Inc. (1)
Global Blood Therapeutics, Inc. (1)
HedgePath Pharmaceuticals, Inc. (2)
Immune Therapeutics, Inc. (1)
MATEON THERAPEUTICS INC (2)
Nuo Therapeutics, Inc. (1)
Orgenesis Inc. (3)
Outlook Therapeutics, Inc. (1)
PharmaCyte Biotech, Inc. (1)
PLURISTEM THERAPEUTICS INC (2)
Protalix BioTherapeutics, Inc. (1)
Qrons Inc. (1)
REGENERX BIOPHARMACEUTICALS INC (1)
Sorrento Therapeutics, Inc. (6)
TENAX THERAPEUTICS, INC. (1)
WINDTREE THERAPEUTICS INC (1)

Recent Contracts

Binding Term Sheet, dated as of February 26, 2024, between Orgenesis Maryland LLC and Germfree Laboratories LLC (Orgenesis Inc., Filed With SEC on March 1, 2024)
Term Sheet, dated as of January 18, 2024, between the Company and MM OS Holdings L.P (Orgenesis Inc., Filed With SEC on January 24, 2024)
Binding Term Sheet (Calyxt, Inc., Filed With SEC on October 25, 2023)
DIP Term Sheet (Clovis Oncology, Inc., Filed With SEC on December 19, 2022)
Form of Term Sheet, by and between the Representative and the Company, dated July 29, 2022 (AzurRx BioPharma, Inc., Filed With SEC on July 29, 2022)
Term Sheet (Immune Therapeutics, Inc., Filed With SEC on July 7, 2022)
Term Sheet between Oncotelic Therapeutics, Inc. and Autotelic, Inc., dated August 31, 2021 (MATEON THERAPEUTICS INC, Filed With SEC on September 3, 2021)
Binding Term Sheet between Protalix Ltd. and Chiesi Farmaceutici S.p.A (Protalix BioTherapeutics, Inc., Filed With SEC on May 14, 2021)
Binding Term Sheet by and between Adamas Pharma, LLC and Zydus Worldwide DMCC and Zydus Pharmaceuticals (USA) Inc (Adamas Pharmaceuticals Inc, Filed With SEC on May 10, 2021)
Amendment to Binding Term Sheet, dated as of April 20, 2021, by and between Sorrento Therapeutics, Inc. and ANP Technologies, Inc (Sorrento Therapeutics, Inc., Filed With SEC on May 5, 2021)
Binding Term Sheet, dated as of February 24, 2021, by and between Sorrento Therapeutics, Inc. and ANP Technologies, Inc (Sorrento Therapeutics, Inc., Filed With SEC on May 5, 2021)
Binding Term Sheet, dated as of October 14, 2020, by and between Sorrento Therapeutics, Inc. and ACEA Therapeutics, Inc (Sorrento Therapeutics, Inc., Filed With SEC on February 19, 2021)
NantCell Binding Termsheet (MATEON THERAPEUTICS INC, Filed With SEC on June 16, 2020)
Binding Term Sheet dated March 18, 2020, between Windtree and Lees Pharmaceutical (HK) LTD (WINDTREE THERAPEUTICS INC, Filed With SEC on May 6, 2020)
Binding Term Sheet by and between Adamas Pharma, LLC and Sandoz, Inc (Adamas Pharmaceuticals Inc, Filed With SEC on February 25, 2020)
TERM SHEET EFFECTIVE AS OF JULY 1, 2019: BETWEEN QRONS INC. AND DR. JOHN N. BONFIGLIO (Qrons Inc., Filed With SEC on June 27, 2019)
Term Sheet, Convertible Preferred Equity Investment in Oncobiologics, Inc. by and between Oncobiologics, Inc. and GMS Tenshi Holdings Pte. Limited, dated June 20, 2018 (Outlook Therapeutics, Inc., Filed With SEC on August 14, 2018)
Amendment No. 2 to Binding Term Sheet by and between Pluristem Therapeutics Inc. and Sosei Corporate Venture Capital Ltd., dated August 15, 2017 (English version only) (PLURISTEM THERAPEUTICS INC, Filed With SEC on September 7, 2017)
Binding Term Sheet between Austrianova Singapore Pte. Ltd. andSG Austria Pte. Ltd. and PharmaCyte Biotech, Inc. (PharmaCyte Biotech, Inc., Filed With SEC on September 6, 2017)
BINDING TERM SHEET FOR VIRTTU BIOLOGICS ACQUISITION (Sorrento Therapeutics, Inc., Filed With SEC on March 22, 2017)
TERM SHEET October 25, 2016 (PLURISTEM THERAPEUTICS INC, Filed With SEC on February 8, 2017)
BINDING TERM SHEET August 15, 2016 (Sorrento Therapeutics, Inc., Filed With SEC on November 9, 2016)
BINDING TERM SHEET FOR sCILEX PHARMACEUTICALS, INc. ACQUISITION AUGUST 2, 2016 (Sorrento Therapeutics, Inc., Filed With SEC on November 9, 2016)
Pricing Term Sheet [None.] (Global Blood Therapeutics, Inc., Filed With SEC on June 20, 2016)
ALKERMES PUBLIC LIMITED COMPANY 5,917,160 Ordinary Shares Pricing Term Sheet (Alkermes plc., Filed With SEC on January 13, 2014)
Term sheet with Mediapark Investments Limited (Orgenesis Inc., Filed With SEC on December 17, 2013)
LEES PHARMACEUTICAL (HK) LIMITED/REGENERX BIOPHARMACEUTICALS, INC. PROPOSED LICENSING TRANSACTION BINDING TERM SHEET *HIGHLY CONFIDENTIAL* March 16, 2012 (REGENERX BIOPHARMACEUTICALS INC, Filed With SEC on May 15, 2012)
Summary Term Sheet (TENAX THERAPEUTICS, INC., Filed With SEC on January 7, 2008)
Term Sheet Agreement (Nuo Therapeutics, Inc., Filed With SEC on November 14, 2007)
TERMS SHEET COMMONWEALTH BIOTECHNOLOGIES INC (HedgePath Pharmaceuticals, Inc., Filed With SEC on April 25, 2007)
TERMS SHEET COMMONWEALTH BIOTECHNOLOGIES INC (HedgePath Pharmaceuticals, Inc., Filed With SEC on April 24, 2007)
EXHIBIT 10.7 (A) Termination and Mutual Release Agreement dated January 17, 2006 (B) Restated Finder Agreement dated August 1, 2005 (C) Finder Agreement dated June 15, 2005... (Alliqua BioMedical, Inc., Filed With SEC on January 24, 2006)